REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 151 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,088 | -99.9% | 182 | -99.7% | 0.00% | -100.0% |
| Q2 2023 | $1,485,062 | +62.3% | 58,675 | +106.6% | 0.00% | +50.0% |
| Q1 2023 | $914,891 | -37.7% | 28,404 | -64.3% | 0.00% | -33.3% |
| Q4 2022 | $1,467,531 | -64.7% | 79,498 | -48.5% | 0.00% | -66.7% |
| Q3 2022 | $4,161,000 | +749.2% | 154,228 | +333.9% | 0.01% | +800.0% |
| Q2 2022 | $490,000 | -36.8% | 35,543 | -10.7% | 0.00% | 0.0% |
| Q1 2022 | $775,000 | -7.7% | 39,817 | -22.7% | 0.00% | 0.0% |
| Q4 2021 | $840,000 | +388.4% | 51,511 | +782.8% | 0.00% | – |
| Q2 2021 | $172,000 | +5.5% | 5,835 | 0.0% | 0.00% | – |
| Q1 2021 | $163,000 | -87.5% | 5,835 | -88.8% | 0.00% | -100.0% |
| Q3 2020 | $1,307,000 | +44.9% | 52,050 | +40.7% | 0.00% | +50.0% |
| Q2 2020 | $902,000 | +481.9% | 36,996 | +210.9% | 0.00% | – |
| Q3 2019 | $155,000 | -60.9% | 11,900 | -61.0% | 0.00% | -100.0% |
| Q2 2019 | $396,000 | +127.6% | 30,513 | +268.1% | 0.00% | – |
| Q4 2016 | $174,000 | – | 8,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
| Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
| Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
| HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
| Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
| Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
| Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
| Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
| Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |